ARCHIVES

Rauscher Explains Reasons for Treatment Switches

This article is from The Cancer Letter archive.

Vol. 01 No. 19 | May 9, 1975

Download PDF Visit The Full Archive

Related Articles

Hayloc, Krebs Lead Oncology Nurses

May 16, 1997

Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies

May 11, 2012

Susan Horwitz Succeeds Waun Ki Hong As AACR President

April 12, 2002

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014

Researchers Identify Nine Cancer Genes-Five Linked to CLL For The First Time

December 30, 2011

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012